Magnesium Supplementation Shows Promise for Cognitive Protection in Older Adults

A Vanderbilt University study examined whether targeted magnesium supplementation could improve cognitive function in older adults consuming high calcium-to-magnesium ratio diets. The research was motivated by the alarming 123% increase in Alzheimer's mortality between 2000-2015 and the lack of approved drugs to slow disease progression.

The randomized controlled trial enrolled 129 participants aged 65 and older who were in good general health but consumed diets with elevated calcium-to-magnesium ratios. Participants received either magnesium glycinate supplements or placebo for three months, with dosing personalized to achieve a target calcium-to-magnesium ratio of 2.3.

The study design represented a precision medicine approach, targeting specific individuals based on their dietary mineral intake patterns rather than applying broad supplementation protocols. Researchers also conducted molecular studies to understand the underlying mechanisms of any observed effects.

This prevention-focused strategy addresses a critical gap in Alzheimer's research, where delaying disease onset by just five years could reduce incidence rates by half. The trial completed in June 2022 after a decade-long study period, though specific results have not yet been published.

The implications extend beyond Alzheimer's prevention to general cognitive health optimization in aging populations. If successful, this personalized mineral balancing approach could offer a simple, accessible intervention for maintaining brain function in older adults, particularly those with calcium-heavy dietary patterns common in Western diets.